FAM108B1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.52951999999873E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.8866000001404E-07 |
Normal-vs-Stage2 |
2.258600E-03 |
Normal-vs-Stage3 |
3.862600E-03 |
Normal-vs-Stage4 |
3.751500E-04 |
Stage1-vs-Stage2 |
4.446000E-01 |
Stage1-vs-Stage3 |
2.956600E-01 |
Stage1-vs-Stage4 |
7.477200E-01 |
Stage2-vs-Stage3 |
8.863000E-01 |
Stage2-vs-Stage4 |
3.435000E-01 |
Stage3-vs-Stage4 |
3.261200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.12440000002534E-06 |
Normal-vs-AfricanAmerican |
5.394000E-04 |
Normal-vs-Asian |
4.724900E-03 |
Caucasian-vs-AfricanAmerican |
4.741800E-01 |
Caucasian-vs-Asian |
6.893800E-01 |
AfricanAmerican-vs-Asian |
5.489000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.6077000003788E-08 |
Normal-vs-Female |
1.429850E-02 |
Male-vs-Female |
2.164600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.76879999999847E-05 |
Normal-vs-Extreme_Weight |
2.80359999660362E-08 |
Normal-vs-Obese |
1.141010E-03 |
Normal-vs-Extreme_Obese |
8.441800E-04 |
Normal_Weight-vs-Extreme_Weight |
5.472000E-01 |
Normal_Weight-vs-Obese |
2.914200E-01 |
Normal_Weight-vs-Extreme_Obese |
9.346000E-01 |
Extreme_Weight-vs-Obese |
2.828200E-02 |
Extreme_Weight-vs-Extreme_Obese |
7.469400E-01 |
Obese-vs-Extreme_Obese |
4.313600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.969800E-04 |
Normal-vs-Age(41-60Yrs) |
2.797700E-04 |
Normal-vs-Age(61-80Yrs) |
8.55039999914098E-08 |
Normal-vs-Age(81-100Yrs) |
3.356700E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.558600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.279800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.278800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.357100E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.567000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.908400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.93259999956308E-07 |
Normal-VS-Type2 PRCC |
3.89200000000534E-05 |
Normal-VS-KIRP CIMP |
7.659300E-03 |
Normal-VS-Unclassified PRCC |
1.658940E-03 |
Type1 PRCC-VS-Type2 PRCC |
9.708200E-01 |
Type1 PRCC-VS-KIRP CIMP |
7.599800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.929200E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.099200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
6.828000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
9.875800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.08689999994893E-06 |
Normal-vs-N1 |
3.302200E-03 |
Normal-vs-N2 |
7.619700E-03 |
N0-vs-N1 |
3.406800E-01 |
N0-vs-N2 |
5.853000E-01 |
N1-vs-N2 |
3.609400E-01 |
|
|